Welcome to LookChem.com Sign In|Join Free

CAS

  • or

63190-44-3

Post Buying Request

63190-44-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

63190-44-3 Usage

Description

Ethyl cyclopropanecarbimidate hydrochloride is a carbamate derivative synthesized from the reaction of ethyl cyclopropanecarbimidate with hydrochloric acid. It is recognized for its potential biological activity, particularly as an enzyme inhibitor, and is utilized in organic synthesis and pharmaceutical research. Due to its irritant and toxic properties, it is handled and stored following standard laboratory safety protocols.

Uses

Used in Organic Synthesis:
Ethyl cyclopropanecarbimidate, HCl is used as a reagent in organic synthesis for its ability to facilitate various chemical reactions, contributing to the formation of complex organic compounds.
Used in Pharmaceutical Research:
In pharmaceutical research, ethyl cyclopropanecarbimidate, HCl is used as a research tool to explore its potential biological activity, including its role as an enzyme inhibitor, which can be crucial in understanding and developing new therapeutic agents.
Used in Enzyme Inhibition:
Ethyl cyclopropanecarbimidate, HCl is used as an enzyme inhibitor for its potential to modulate enzyme activity, which can be significant in the development of treatments for certain diseases where enzyme dysregulation is implicated.
Used in Drug Development:
In the pharmaceutical industry, ethyl cyclopropanecarbimidate, HCl is used in the preparation of various pharmaceutical compounds, leveraging its properties to enhance drug efficacy and target specific biological pathways.
Used in Therapeutic Agent Research:
Ethyl cyclopropanecarbimidate, HCl is studied for its potential as a therapeutic agent, particularly in the treatment of certain diseases, where its biological activity could offer novel treatment options.

Check Digit Verification of cas no

The CAS Registry Mumber 63190-44-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,3,1,9 and 0 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 63190-44:
(7*6)+(6*3)+(5*1)+(4*9)+(3*0)+(2*4)+(1*4)=113
113 % 10 = 3
So 63190-44-3 is a valid CAS Registry Number.

63190-44-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name ethyl cyclopropanecarboximidate,hydrochloride

1.2 Other means of identification

Product number -
Other names ethyl cyclopropanecarbimidate hydrochloride

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:63190-44-3 SDS

63190-44-3Relevant articles and documents

Synthesis and molecular docking study of some 5,6-dichloro-2-cyclopropyl-1H-benzimidazole derivatives bearing triazole, oxadiazole, and imine functionalities as potent inhibitors of urease

Mente?e, Emre,Bekta?, Hakan,Sokmen, Bahar Bilgin,Emirik, Mustafa,?ak?r, Demet,Kahveci, Bahittin

, p. 3014 - 3018 (2017)

A new series of benzimidazole compounds including hydrazinecarbothioamide, 1,2,4-triazole, 1,3,4-oxadiazole and imine function were synthesized starting from 5,6-dichloro-2-cyclopropyl-1H-benzimidazole. All of the benzimidazole derivatives exhibited good urease inhibitor activity. Compound 6a proved to be the most potent showing an enzyme inhibitory activity with an IC50?=?0.06?μM. Molecular docking studies were also conducted on enzyme extracted from Jack bean urease to identify the binding mode of the newly synthesized compounds.

ASK1 inhibitor, derivative, preparation method, pharmaceutical composition and application thereof

-

Paragraph 0170-0175, (2021/02/10)

The invention discloses an ASK1 inhibitor, a derivative, a preparation method, a pharmaceutical composition and application thereof. The structure of the compound is shown as a formula I. The ASK1 inhibitor derivative relates to an isomer, a diastereoisom

IMIDAZOPIPERAZINONE INHIBITORS OF TRANSCRIPTION ACTIVATING PROTEINS

-

Paragraph 0514; 0515, (2019/10/20)

The present disclosure relates to heterocyclic compounds and methods which may be useful as inhibitors of transcription activating proteins such as CBP and P300 for the treatment or prevention of diseases such as proliferative diseases, inflammatory disorders, autoimmune diseases, and fibrotic diseases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 63190-44-3